Common aspirin pill may hold key to stopping colon Cancer's return
NCT ID NCT02945033
Summary
This study is testing if taking a daily low-dose aspirin pill can prevent colon cancer from returning after surgery. It will involve 264 patients whose cancer has a specific genetic change (PI3K mutation). Participants will be randomly assigned to take either aspirin or a placebo (sugar pill) for several years to see which group has fewer cancer recurrences.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rouen University Hospital
RECRUITINGRouen, France
Contact
Conditions
Explore the condition pages connected to this study.